Comment on 'Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study'

被引：0

作者：

Johnson, Chandler ^{[1
]}

Smith, Payton ^{[1
]}

Haran, Kathryn ^{[1
]}

Kranyak, Allison ^{[1
]}

Liao, Wilson ^{[1
]}

Bhutani, Tina ^{[1
]}

机构：

[1] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 190卷 / 04期

关键词：

D O I：

10.1093/bjd/ljad529

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

In this letter to the editor, we respond to the article by Merola et al. titled 'Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study'. We add to the authors' discussion on the discrepancy between objective and subjective measures of sleep in people with atopic dermatitis treated with dupilumab.

引用

页码：596 / 596

页数：1

共 50 条

[1] Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study
Merola, Joseph F.
Chiou, Albert S.
During, Emmanuel
Costanzo, Antonio
Foley, Peter
Alfalasi, Amani
Gogate, Shaila
Pinter, Andreas
Dodiuk-Gad, Roni
Simon, Dagmar
Tauber, Marie
Weller, Richard
Pereyra-Rodriguez, Jose-Juan
Ardeleanu, Marius
Wu, Jiangming
Ozturk, Zafer E.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (06) : 685 - 694
[2] Dupilumab Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study
Bieber, Thomas R. M.
Thaci, Diamant
Graham, Neil
Pirozzi, Gianluca
Teper, Ariel
Ren, Haobo
Radin, Allen
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB404 - AB404
[3] Oral hyaluronan relieves wrinkles: a double-blinded, placebo-controlled study over a 12-week period
Oe, Mariko
Sakai, Seigo
Yoshida, Hideto
Okado, Nao
Kaneda, Haruna
Masuda, Yasunobu
Urushibata, Osamu
[J]. CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2017, 10 : 267 - 273
[4] Oral Hyaluronan Relieves Wrinkles and Improves Dry Skin: A 12-Week Double-Blinded, Placebo-Controlled Study
Hsu, Tzu-Fang
Su, Zi-Rong
Hsieh, Yao-Hao
Wang, Ming-Fu
Oe, Mariko
Matsuoka, Ryosuke
Masuda, Yasunobu
[J]. NUTRIENTS, 2021, 13 (07)
[5] Oral sodium hyaluronate relieves knee discomfort: A 12-week double-blinded, placebo-controlled study
Sugiyama, Kiichi
Oe, Mariko
Tanaka, Tomomi
Matsuoka, Ryosuke
Takeda, Yumi
Kimura, Mamoru
Odani, Koji
[J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (02)
[6] METHYLPHENIDATE FOR ADHD IN ADULTS WITH SUBSTANCE DEPENDENCE A 24-WEEK RANDOMIZED PLACEBO-CONTROLLED TRIAL
Konstenius, M.
Jayaram-Lindstrom, N.
Guterstam, J.
Philips, B.
Beck, O.
Franck, J.
[J]. EUROPEAN PSYCHIATRY, 2013, 28
[7] Efficacy and safety of oral palmitoleic acid supplementation for skin barrier improvement: A 12-week, randomized, double-blinded, placebo-controlled study
Koh, Young Gue
Seok, Joon
Park, Jae Wan
Kim, Ka Ram
Yoo, Kwang Ho
Kim, Yong Joon
Kim, Beom Joon
[J]. HELIYON, 2023, 9 (06)
[8] A prospective randomized, double-blinded, placebo-controlled pilot study of lactobacillus GG in the treatment of atopic dermatitis
Bard, Susan
Kroshinsky, Daniela
Solomon, Hormoz
Glick, Sharon
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB53 - AB53
[9] Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial
Guttman-Yassky, Emma
Thaci, Diamant
Pangan, Aileen L.
Hong, H. Chih-ho
Papp, Kim A.
Reich, Kristian
Beck, Lisa A.
Mohamed, Mohamed-Eslam F.
Othman, Ahmed A.
Anderson, Jaclyn K.
Gu, Yihua
Teixeira, Henrique D.
Silverberg, Jonathan I.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (03) : 877 - 884
[10] Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
Blauvelt, Andrew
Thyssen, Jacob P.
Guttman-Yassky, Emma
Bieber, Thomas
Serra-Baldrich, Esther
Simpson, Eric
Rosmarin, David
Elmaraghy, Hany
Meskimen, Eric
Natalie, Chitra R.
Liu, Zhuqing
Xu, Chenjia
Pierce, Evangeline
Morgan-Cox, MaryAnn
Gil, Esther Garcia
Silverberg, Jonathan, I
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (06) : 740 - 748

← 1 2 3 4 5 →